NiKang Therapeutics Enters into Clinical Trial Collaboration and Supply Agreement to Evaluate NKT2152 in Combination with Standard-of-Care in First-Line Advanced Hepatocellular Carcinoma
– Study will evaluate the potential of triple combination of NKT2152, atezolizumab and bevacizumab versus atezolizumab and bevacizumab alone, in first line... Read more.
Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer (mBC) with ESR1 Mutations at SABCS 2023
This new post hoc analysis of the Phase 3 EMERALD trial evaluated elacestrant in the endocrine-sensitive population (CDK4/6 inhibitor duration of at least 12 months)... Read more.
Advisor2X Welcomes Andrew Wexler as Director of Business Development
The seasoned industry veteran will lead the company’s growth effort WILMINGTON, N.C.–(BUSINESS WIRE)–Advisor2X (A2X), delivering online shows and live... Read more.
Global Robotic Smart Motors Industry Analysis and Forecast Report 2023-2033: Growing Demand for Advanced Autonomous Robotic Systems and Integration of Smart Motors with IoT Capabilities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Robotic Smart Motors Market – A Global and Regional Analysis: Focus on Robot Type, Voltage, Component, and Country... Read more.
Wilshire Completes Acquisition of Lyxor U.S.
SANTA MONICA, Calif.–(BUSINESS WIRE)–Wilshire, a leading global financial services firm, today announced the completion of its previously announced acquisition... Read more.
ICE Announces Approval of Electronic Trade Document Solution for the Delivery of Commodities Globally
LONDON–(BUSINESS WIRE)–Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of data, technology, and market infrastructure, today announced... Read more.
European Commission Approves Pfizer’s ELREXFIO® for Relapsed and Refractory Multiple Myeloma
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial ELREXFIO... Read more.
EDF Australia commits Euro 10 million to Vast
SYDNEY & HOUSTON–(BUSINESS WIRE)–EDF Australia (“EDF Australia”) today announced a Euro 10 million commitment to Vast Renewables Limited (“Vast”),... Read more.
American Equity Celebrates 20th Anniversary of NYSE Listing
Rings NYSE Opening Bell to Commemorate Milestone on Friday, December 8th WEST DES MOINES, Iowa–(BUSINESS WIRE)–American Equity Investment Life Holding... Read more.
Global Hemoglobin A1C (HbA1C) Testing Strategic Research Report 2023: Market to Reach $2.3 Billion by 2030 from $1.4 Billion in 2022 – Benefits of POC HbA1c Tests Over Lab Tests Drives Adoption – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Hemoglobin A1C (HbA1C) Testing – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s... Read more.